Itron, Inc. (NASDAQ:ITRI) Stock Has Average Price Target of $131.33

by · The Cerbat Gem

Itron, Inc. (NASDAQ:ITRI – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $131.33.

A number of brokerages recently weighed in on ITRI. Weiss Ratings restated a “hold (c)” rating on shares of Itron in a research report on Wednesday, August 5th. Seaport Research Partners reiterated a “buy” rating and issued a $150.00 price target on shares of Itron in a research note on Wednesday, July 29th. Needham & Company LLC increased their price objective on shares of Itron from $116.00 to $128.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. Robert W. Baird set a $125.00 target price on Itron in a report on Wednesday, July 29th. Finally, Zacks Research upgraded Itron from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 27th.

Get Our Latest Research Report on ITRI

Itron Stock Performance

NASDAQ:ITRI opened at $85.58 on Wednesday. The stock has a 50-day moving average price of $95.17 and a 200 day moving average price of $89.35. The stock has a market capitalization of $3.75 billion, a P/E ratio of 14.29, a P/E/G ratio of 1.01 and a beta of 1.32. Itron has a 12-month low of $77.77 and a 12-month high of $142.00. The company has a current ratio of 2.75, a quick ratio of 2.29 and a debt-to-equity ratio of 0.96.

Itron (NASDAQ:ITRI – Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.30. Itron had a return on equity of 19.26% and a net margin of 11.90%. The business had revenue of $562.90 million during the quarter, compared to the consensus estimate of $566.34 million. During the same period in the prior year, the company posted $1.62 EPS. The firm’s revenue for the quarter was down 7.2% compared to the same quarter last year. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Equities research analysts forecast that Itron will post 6.41 EPS for the current fiscal year.

Insider Buying and Selling at Itron

In other Itron news, CFO Joan Hooper sold 455 shares of Itron stock in a transaction on Monday, August 24th. The shares were sold at an average price of $98.79, for a total value of $44,949.45. Following the completion of the transaction, the chief financial officer directly owned 118,440 shares of the company’s stock, valued at $11,700,687.60. This trade represents a 0.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Justin Patrick sold 10,210 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $97.36, for a total transaction of $994,045.60. Following the completion of the sale, the senior vice president owned 22,065 shares in the company, valued at approximately $2,148,248.40. This trade represents a 31.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,903 shares of company stock worth $1,753,521. Company insiders own 1.77% of the company’s stock.

Institutional Investors Weigh In On Itron

Several institutional investors have recently modified their holdings of ITRI. Capital World Investors purchased a new stake in shares of Itron during the fourth quarter valued at $10,460,000. Assenagon Asset Management S.A. increased its stake in Itron by 160.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 336,710 shares of the scientific and technical instruments company’s stock worth $29,136,000 after buying an additional 207,416 shares during the period. Fieldview Capital Management LLC increased its stake in Itron by 54.1% in the 4th quarter. Fieldview Capital Management LLC now owns 40,095 shares of the scientific and technical instruments company’s stock worth $3,723,000 after buying an additional 14,079 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in Itron by 12.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock valued at $60,359,000 after buying an additional 73,020 shares in the last quarter. Finally, Readystate Asset Management LP bought a new stake in Itron during the 2nd quarter valued at about $1,809,000. 96.19% of the stock is owned by institutional investors.

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) provides technology and services that help utilities and cities manage electricity, natural gas, and water resources. Its solutions are designed to improve the measurement, collection, and analysis of usage data while supporting grid modernization, operational efficiency, and resource conservation.

The company’s offerings include smart meters, advanced metering infrastructure, communications networks, sensors, data-management software, and analytics platforms.

See Also